Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.39
+0.08 (1.51%)
At close: Oct 31, 2025, 4:00 PM EDT
5.54
+0.15 (2.78%)
After-hours: Oct 31, 2025, 7:58 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $419.71 million as of October 31, 2025. Its market cap has increased by 55.13% in one year.
Market Cap
419.71M
Enterprise Value
174.66M
1-Year Change
55.13%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $419.71M, a decrease of -94.25%. That is a compound annual growth rate of -30.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 419.71M | 162.62% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |